|
1.
|
No authors listed:. Report of a Joint
FAO/WHO Expert Consultation: Carbohydrates in human nutrition. FAO
Food Nutr Pap. 66:1–140. 1998.
|
|
2.
|
Englyst HN, Kingman SM and Cummings JH:
Classification and measurement of nutritionally important starch
fractions. Eur J Clin Nutr. 46(Suppl 2): S33–S50. 1992.PubMed/NCBI
|
|
3.
|
Baghurst PA, Baghurst KI and Record SJ:
Dietary fiber, non-starch polysaccharides and resistant starch - a
review. Food Australia. 48(Suppl): S1–S36. 1996.
|
|
4.
|
Yin J, Yang G, Wang S and Chen Y:
Purification and determination of stachyose in Chinese artichoke
(Stachys Sieboldii Miq.) by high-performance liquid
chromatography with evaporative light scattering detection.
Talanta. 70:208–212. 2006.PubMed/NCBI
|
|
5.
|
Liying Z, Li D, Qiao S, Johnson EW, Li B,
Thacker PA and Han IK: Effects of stachyose on performance,
diarrhoea incidence and intestinal bacteria in weanling pigs. Arch
Tierernahr. 57:1–10. 2003.PubMed/NCBI
|
|
6.
|
Macfarlane GT and Cummings JH: Probiotics
and prebiotics: can regulating the activities of intestinal
bacteria benefit health? West J Med. 171:187–191. 1999.
|
|
7.
|
Xu Q, Chao YL and Wan QB: Health benefit
application of functional oligosaccharides. Carbohydrate Polymers.
77:435–441. 2009. View Article : Google Scholar
|
|
8.
|
Jian R, Besterman HS, Sarson DL, et al:
Colonic inhibition of gastric secretion in man. Dig Dis Sci.
26:195–201. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Seo GS and Choi SC: Pathophysiology of
ulcerative colitis - relationship with genetics and immunity. Korea
J Med. 76:643–648. 2009.(In Korean).
|
|
10.
|
Stange EF, Travis SP, Vermeire S,
Beglinger C, Kupcinkas L, Geboes K, et al European Crohn’s and
Colitis Organisation: European evidence based consensus on the
diagnosis and management of Crohn’s disease: definitions and
diagnosis. Gut. 55(Suppl 1): 1–15. 2006.
|
|
11.
|
Ramadori G and Armbrust T: Cytokines in
the liver. Eur J Gastroenterol Hepatol. 13:777–784. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
McCurry KR, Campbell DA Jr, Scales WE,
Warren JS and Remick DG: Tumor necrosis factor, interleukin 6, and
the acute phase response following hepatic ischemia/reperfusion. J
Surg Res. 55:49–54. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Ming WJ, Bersani L and Mantovani A: Tumor
necrosis factor is chemotactic for monocytes and polymorphonuclear
leukocytes. J Immunol. 138:1469–1472. 1987.PubMed/NCBI
|
|
14.
|
Fayyaz M and Lackner JM: Serotonin
receptor modulators in the treatment of irritable bowel syndrome.
Ther Clin Risk Manag. 4:41–48. 2008.PubMed/NCBI
|
|
15.
|
Melgar S, Karlsson L, Rehnström E,
Karlsson A, Utkovic H, Jansson L and Michaëlsson E: Validation of
murine dextran sulfate sodium-induced colitis using four
therapeutic agents for human inflammatory bowel disease. Int
immunopharmacol. 8:836–844. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Ogawa A, Andoh A, Araki Y, Bamba T and
Fujiyama Y: Neutralization of interleukin-17 aggravates dextran
sulfate sodium-induced colitis in mice. Clin Immunol. 110:55–62.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Soriano A, Salas A, Salas A, Sans M,
Gironella M, Elena M, Anderson DC, Piqué JM and Panés J: VCAM-1,
but not ICAM-1 or MAdCAM-1, immunoblockade ameliorates DSS-induced
colitis in mice. Lab Invest. 80:1541–1551. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Ferguson-Smith AC, Chen YF, Newman MS, May
LT, Sehgal PB and Ruddle FH: Regional localization of the
interferon-beta 2/B-cell stimulatory factor 2/hepatocyte
stimulating factor gene to human chromosome 7p15–p21. Genomics.
2:203–208. 1988.PubMed/NCBI
|
|
19.
|
van der Poll T, Keogh CV, Guirao X,
Buurman WA, Kopf M and Lowry SF: Interleukin-6 gene-deficient mice
show impaired defense against pneumococcal pneumonia. J Infect Dis.
176:439–444. 1997.PubMed/NCBI
|
|
20.
|
Gosselin D and Rivest S: Role of IL-1 and
TNF in the brain: twenty years of progress on a Dr. Jekyll/Mr Hyde
duality of the innate immune system. Brain Behav Immun. 21:281–289.
2007.PubMed/NCBI
|
|
21.
|
Wan GS, Zhao ZZ, Qian YL, Xie ZH, Wang ZH
and Zhu JJ: Changes in serum levels of SOCS-3, IL-6 and TNF-α and
their correlation in patients with ulcerative colitis. World
Chinese J Digestol. 19:3370–3373. 2011.(In Chinese).
|
|
22.
|
Barondeau DP, Kassmann CJ, Bruns CK,
Tainer JA and Getzoff ED: Nickel superoxide dismutase structure and
mechanism. Biochemistry. 43:8038–8047. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Gaze DC: The role of existing and novel
cardiac biomarkers for cardioprotection. Curr Opin Investig Drugs.
8:711–717. 2007.PubMed/NCBI
|
|
24.
|
Alscher RG, Erturk N and Heath LS: Role of
superoxide dismutases (SODs) in controlling oxidative stress in
plants. J Exp Bot. 53:1331–1341. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Topping DL and Clifton PM: Short-chain
fatty acids and human colonic function: roles of resistant starch
and nonstarch polysaccharides. Physiol Rev. 81:1031–1064.
2001.PubMed/NCBI
|
|
26.
|
Berggren AM, Bjorck IM, Nyman EM and Eggum
BO: Short-chain fatty acid content and pH in caecum of rats given
various sources of carbohydrates. J Sci Food Agri. 63:397–406.
1993.
|
